このエントリーをはてなブックマークに追加
ID 30488
JaLCDOI
FullText URL
Author
Kobayashi, Kazuko
Han, Mei
Watarai, Shinobu
Abstract

<P>Phospholipid vesicles, also known as liposomes, were examined for their ability to act as a drug carrier to the brain. 9-Amino-1,2,3,4-tetrahydroacridine (THA), a centrally acting acetylcholinesterase inhibitor, was used as a model drug. THA was encapsulated in dehydration-rehydration vesicles (DRV) composed of egg yolk phosphatidylcholine, cholesterol and dipalmitoyl-phosphatidic acid (molar ratio, 10/10/1) and injected into the heart of mice. The toxicity and side effects of THA were reduced by encapsulation in liposomes. The THA concentration in the mouse brain after injection of THA-encapsulated DRV at a dose of 2 mg/kg remained higher than that of free THA at the same dose. Effective concentration of THA in the brain was also prolonged by the use of liposomes, although accumulation of THA in the spleen and kidney was observed. We, therefore, concluded that liposomes are useful as carriers of drugs to the brain.</P>

Keywords
brain targeting
liposomes
mouse
THA(9-amino-1
2
3
4
-tetrahydroacridin)
Amo Type
Article
Published Date
1996-04
Publication Title
Acta Medica Okayama
Volume
volume50
Issue
issue2
Publisher
Okayama University Medical School
Start Page
67
End Page
72
ISSN
0386-300X
NCID
AA00508441
Content Type
Journal Article
language
英語
File Version
publisher
Refereed
True
PubMed ID
Web of Science KeyUT